Anti-Mllerian hormone (AMH) is a glycoprotein hormone produced by granulosa cells in ovarian follicles. Its levels in the blood are often used as an indicator of ovarian reserve, which is the quantity and quality of a woman’s remaining eggs. Lower levels of AMH may suggest a reduced ovarian reserve, which can be a concern for women planning to conceive. A crucial question for many women is whether there are strategies to influence these levels and potentially improve their fertility prospects.
Understanding factors influencing AMH is of significant benefit because it aids in family planning decisions and informs fertility treatment options. Low AMH does not necessarily mean pregnancy is impossible, but it might indicate a need to expedite conception efforts or consider assisted reproductive technologies. Historically, AMH testing has become increasingly important in the field of reproductive endocrinology as a tool for assessing a womans potential response to ovarian stimulation during in vitro fertilization (IVF).
